In the News

FDA APPROVES ZEPHYR ENDOBRONCHIAL VALVE FOR TREATING SEVERE EMPHYSEMA

The US Food and Drug Administration (FDA) has approved the Zephyr® Endobronchial Valve System for treating severe emphysema patients.

Read More


ZEPHYR ENDOBRONCHIAL VALVES IMPROVE BREATHING, QUALITY OF LIFE AND ACTIVITY FOR SEVERE EMPHYSEMA PATIENTS IN US PIVOTAL TRIAL

Pulmonx®Corp. today announced positive one-year results from the U.S. LIBERATE pivotal trial of the Zephyr® Endobronchial Valve, a minimally-invasive treatment for severe emphysema, an advanced form of chronic obstructive pulmonary disease (COPD).

Read More